BioCentury
ARTICLE | Company News

SkyePharma contract with Kowa

February 12, 2001 8:00 AM UTC

SkyePharma (LSE:SKP; SKYE) will provide materials for the scale-up and manufacturing of Phase III batches of Kowa's NK-104 lipid-lowering agent to treat high cholesterol (see BioCentury, Feb. 12). Th...